QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it will showcase its oncology workflow applications at the American Association for Cancer Research (AACR) Annual Meeting 2026 ...

Qiagen is moving into syndromic testing for bloodstream infections with the launch of the Netherlands-based diagnostics maker ...

Qiagen N.V. (NYSE:QGEN) is one of the 10 potential takeover targets with strong price momentum. The latest relevant ...

According to MarketsandMarkets™, the Gene Expression Analysis Market is projected to grow from about USD 4.23 billion in 2026 ...

In this article, we take a look at 10 Potential Takeover Targets with Strong Price Momentum. Takeover speculation is getting ...

Fintel reports that on April 14, 2026, Barclays downgraded their outlook for Qiagen N.V. (NYSE:QGEN) from Overweight to Equal ...

The latest announcement is out from Qiagen ( (QGEN) ).

Qiagen ( (QGEN)) just unveiled an update. Qiagen reported that the Dutch financial regulator AFM has disclosed a substantial holdings notification concerning BlackRock, Inc.’s position in the company.

QIAstat-Dx BCID GPF Plus AMR Panel detects gram-positive bacteria, fungi and key antimicrobial resistance markers from positive blood cultures and colonies CE-IVDR-certified panel identifies ...

Bruker Corporation (Nasdaq: BRKR) announces the appointment of Mr. Thierry L. Bernard to serve on its Board of Directors, effective as of today. Mr. Bernard is an international life-science tools and ...

European equities fell on March 27 while oil prices remained high, as concerns about the impact of conflict in the Middle ...

Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode (TM) Whole ...